0001209191-18-056049.txt : 20181024 0001209191-18-056049.hdr.sgml : 20181024 20181024161844 ACCESSION NUMBER: 0001209191-18-056049 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181022 FILED AS OF DATE: 20181024 DATE AS OF CHANGE: 20181024 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mow Jonathan P CENTRAL INDEX KEY: 0001313942 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38697 FILM NUMBER: 181136609 MAIL ADDRESS: STREET 1: 2025 1ST AVENUE STREET 2: SUITE 800 CITY: SEATTLE STATE: WA ZIP: 98121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PhaseBio Pharmaceuticals Inc CENTRAL INDEX KEY: 0001169245 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 030375697 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 GREAT VALLEY PARKWAY STREET 2: SUITE 30 CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: (610) 981-6500 MAIL ADDRESS: STREET 1: 1 GREAT VALLEY PARKWAY STREET 2: SUITE 30 CITY: MALVERN STATE: PA ZIP: 19355 FORMER COMPANY: FORMER CONFORMED NAME: Phase Biosciences Inc DATE OF NAME CHANGE: 20061013 FORMER COMPANY: FORMER CONFORMED NAME: DT BIOSCIENCES INC DATE OF NAME CHANGE: 20020315 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-10-22 0 0001169245 PhaseBio Pharmaceuticals Inc PHAS 0001313942 Mow Jonathan P C/O PHASEBIO PHARMACEUTICALS, INC. 1 GREAT VALLEY PARKWAY, SUITE 30 MALVERN PA 19355 1 1 0 0 Chief Executive Officer Common Stock 2018-10-22 4 C 0 310 A 310 D Common Stock 2018-10-22 4 C 0 3505 A 48699 I By the Mow Trust dated April 17, 2008 Warrants to Purchase Series B Preferred Stock 0.12 2018-10-22 4 M 0 310 0.00 D Series B Preferred Stock 310 0 D Series B Preferred Stock 2018-10-22 4 M 0 310 0.12 A Common Stock 310 310 D Series B Preferred Stock 2018-10-22 4 C 0 310 0.00 D Common Stock 310 0 D Series B Preferred Stock 2018-10-22 4 C 0 3505 0.00 D Common Stock 3505 0 I By the Mow Trust dated April 17, 2008 Each share of Preferred Stock converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering and has no expiration date. The reporting person and his wife are joint trustees of the Mow Trust dated April 17, 2008 and share voting and dispositive power for such shares. The reporting person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein. Represents the exercise of the warrants immediately prior to, and contingent upon, the closing of the Issuer's initial public offering. The warrants were exercisable until, and were scheduled to expire upon, the closing of the Issuer's initial public offering. /s/ Darren K. DeStefano, Attorney-in-Fact 2018-10-24